Lung cancer immunotherapy. Article

Raez, LE, Fein, S, Podack, ER. (2005). Lung cancer immunotherapy. . 3(4), 221-228. 10.3121/cmr.3.4.221

cited authors

  • Raez, LE; Fein, S; Podack, ER



  • Recent insights into anti-tumor immunotherapy have led to a wave of clinical trials involving immunotherapy for lung cancer. Vaccines have evolved from nonspecific immune stimulants, like Bacillus Calmette-Guerin (BCG), to much more specific and potent strategies, some of which generate active immune responses against tumor-associated antigens. Understanding the mechanisms of anti-tumor immunity and identifying target antigens will likely improve these therapeutic strategies and provide them with a niche in the future of lung cancer therapy.

publication date

  • January 1, 2005

Digital Object Identifier (DOI)

start page

  • 221

end page

  • 228


  • 3


  • 4